Mirena (Levonorgestrel)

Levonorgestrel, the active ingredient in Mirena, is a progestin presented as a 52 mg (20 µg/day release) intrauterine system for intrauterine use. It prevents pregnancy, reduces menstrual bleeding, and is also employed to manage heavy menstrual bleeding and endometriosis‑associated pain.

GNH USA supplies Mirena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirena (levonorgestrel) is a hormonal contraceptive that acts on the uterine environment to provide long‑term birth control and manage menstrual disorders.

- Contraception: provides up to five years of highly effective pregnancy prevention. - Heavy menstrual bleeding: reduces menstrual blood loss and improves quality of life. - Endometriosis‑associated pain: alleviates pelvic pain related to endometriosis.

Adverse reactions to Mirena are generally related to local uterine effects and systemic hormonal exposure.

Common Side Effects: - Irregular bleeding: spotting or unpredictable menstrual patterns. - Amenorrhea: absence of menstrual bleeding. - Pelvic pain: cramping or discomfort in the lower abdomen.

Serious or Rare Side Effects: - Uterine perforation: rare injury to the uterine wall during insertion. - Ectopic pregnancy: pregnancy occurring outside the uterus if contraception fails. - Hormone‑dependent tumor growth: potential stimulation of existing estrogen‑sensitive tumors.

Before using Mirena, clinicians should consider several safety measures.

- Screening: confirm no current pregnancy and assess uterine anatomy before insertion. - Contraindications: avoid in women with active pelvic infection, unexplained vaginal bleeding, or known hypersensitivity to levonorgestrel. - Follow‑up: schedule a check‑up 4–6 weeks after insertion to verify placement. - Removal: ensure timely removal or replacement at five years to maintain efficacy. - Store at ambient temperature: keep the device in its original packaging, protect from moisture and direct sunlight.

Levonorgestrel may interact with other medicines that affect hormone metabolism.

Major Interactions (Avoid): - Antiepileptic enzyme inducers: strong inducers such as carbamazepine may reduce levonorgestrel effectiveness. - Rifampicin: may decrease hormone levels leading to reduced contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles: ketoconazole can increase levonorgestrel concentrations. - Antiretrovirals: protease inhibitors may alter hormone metabolism. - Herbal supplements: St. John’s wort may lower efficacy.